Article

OWL names Pamela Gleeson new president

Ophthalmic Women Leaders has appointed Pamela Gleeson, chief financial officer of Santen Inc., as its 2010 president. She previously served as chairwoman of the organization?s finance committee.



San Francisco

-Ophthalmic Women Leaders (OWL) has appointed Pamela Gleeson, chief financial officer (CFO) of Santen Inc., as its 2010 president. She previously served as chairwoman of the organization’s finance committee.

“With a deep understanding of the ophthalmic field, established relationships in the industry, and a strong commitment to mentoring future ophthalmic leaders, Pamela has already moved effortlessly into her role as president with plans for expanding our offerings,” said Molly Schar, executive director of OWL.

“I am thrilled to be serving as president and to be a part of an organization and mentoring program about which I’m very passionate,” said Gleeson. “Additionally, I am fortunate to work with one of OWL’s founding members, Santen CEO Adrienne Graves, who encouraged me to become involved with OWL in its early years.”

Gleeson joined Santen in 1997 and has served as its CFO since 2003. During her time with the company, she has held positions in business development, project management, new product development, and marketing. She also has served on the executive strategy committee. Before joining Santen, Gleeson held finance positions in the high-tech, mortgage banking services, and retail food industries after beginning her career at KPMG.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.